Additionally, a comprehensive analysis of mutations in key meningioma-related transcripts revealed a strong concordance in mutant transcript fractions (Figure 5b), validating MEN-Os as a reliable ex-vivo platform for faithfully capturing the mutational landscape of meningiomas. This evidence concerns the gene MID1 and meningioma.